Surprised there been no comments around this collab considering it sounds to be a product with similar mode of action to Cellpryme
immuno-oncology company Imugene and NeoImmuneTech, a T-cell-focused biopharmaceutical company based in Maryland, USA, have come together to evaluate Imugene’s allogeneic CAR T azer-cel in combination with NeoImmuneTech’s proprietary immune T-cell amplifier NT-I7 for the treatment of cancer.Combined, the two treatments are expected to lead to an increase in the number and cancer-fighting properties of a patient’s own T-cells during their treatment with azer-cel.NeoImmuneTech’s NT-I7 is the only long-acting human interleukin-7 (IL-7) cytokine in clinical stage development and has been found to play a key role in T-cell development and survival, boosting cancer fighting T-cell numbers, their health and functionality to enhance immune function and potentially provide improved cancer fighting benefits to patients.
- Forums
- ASX - By Stock
- PTX
- PTX - Banter and General Comments
PTX - Banter and General Comments, page-158
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PTX (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.1¢ |
Change
0.001(1.25%) |
Mkt cap ! $32.61M |
Open | High | Low | Value | Volume |
4.0¢ | 4.1¢ | 4.0¢ | $34.57K | 860.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 99935 | 4.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.1¢ | 458172 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 99935 | 0.040 |
4 | 433434 | 0.039 |
10 | 1290788 | 0.038 |
3 | 130515 | 0.037 |
5 | 429500 | 0.036 |
Price($) | Vol. | No. |
---|---|---|
0.041 | 458172 | 3 |
0.042 | 200000 | 1 |
0.043 | 347971 | 3 |
0.044 | 210000 | 2 |
0.045 | 407000 | 3 |
Last trade - 15.57pm 21/06/2024 (20 minute delay) ? |
Featured News
PTX (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online